imipramine has been researched along with sb 221284 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hutson, PH; Murray, F | 1 |
1 other study(ies) available for imipramine and sb 221284
Article | Year |
---|---|
Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.
Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Citalopram; Fluorobenzenes; Hippocampus; Imipramine; Indoles; Male; Mice; Piperazines; Piperidines; Proto-Oncogene Proteins c-bcl-2; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sulfonamides | 2007 |